The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Daro-PET: A phase 2 trial of darolutamide as a prostate-specific membrane antigen (PSMA) expression enhancer in patients with localized prostate cancer.
 
Jose Mauricio Mota
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Merck; Pfizer; Zodiac Pharma
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen Oncology; Merck; Pfizer; Zodiac Pharma
Expert Testimony - Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Janssen Oncology; Zodiac Pharma
 
Camila Mosci
No Relationships to Disclose
 
Jéssica Vasconcellos
No Relationships to Disclose
 
Thiago Souto Hemerly
No Relationships to Disclose
 
Deusdedit Cortêz Vieira Silva Neto
No Relationships to Disclose
 
Luis Felipe Brandao
No Relationships to Disclose
 
Victor Srougi
No Relationships to Disclose
 
Rodrigo Nalio Ramos
No Relationships to Disclose
 
Isabela Werneck Cunha
No Relationships to Disclose